|
Feb 2024
As of Feb 29, 2024
|
|
|---|---|
| Cash and cash equivalents | |
| Other current assets | |
| TOTAL ASSETS | |
| LIABILITIES & STOCKHOLDERS' DEFICIT | |
| Current liabilities | |
| Accrued expenses | |
| Related party loans & notes payable, short-term or current | |
| TOTAL LIABILITIES | |
| STOCKHOLDERS' DEFICIT | |
| Preferred stock Series A: par value $0.0001, 5,000,000 authorized and none issued and outstanding at February 29, 2024 and November 30, 2023 | |
| Common stock: par value $0.0001, 25,000,000 authorized and 17,960,633 issued and outstanding at February 29, 2024 and November 30, 2023 | |
| Additional paid-in capital | |
| Accumulated deficit | |
| TOTAL STOCKHOLDERS' DEFICIT | |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...
